Results 11 to 20 of about 16,224 (212)
Zolpidem in Progressive Supranuclear Palsy [PDF]
Case Reports in Neurological Medicine, 2013 Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder.
Sandip K. Dash
doaj +3 more sources
Progressive supranuclear palsy [PDF]
Seminars in Neurology, 2001 Unfortunately, no drug treatment has been shown to benefit patients with progressive supranuclear palsy (PSP) more than modestly or briefly. The multiplicity of neuronal systems and synaptic physiologies that degenerate in this disorder makes a neurotransmitter-specific approach, such as neurotransmitter replacement or reuptake inhibition, unlikely to ...
K, Tawana, D B, Ramsden
openaire +5 more sources
Progressive supranuclear palsy [PDF]
Postgraduate Medical Journal, 2000 Abstract Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski syndrome is a neurodegenerative disease of middle and late age. It is under-diagnosed not only by general physicians but also by neurologists. The cause of PSP is not known.
, Lowrey, , Wong
openaire +4 more sources
Diplopia in Progressive Supranuclear Palsy [PDF]
Movement Disorders Clinical Practice, 2020 View Supplementary Video 1View Supplementary Video ...
Narges, Yazdi +3 more
openaire +2 more sources
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease
NeuroImage: Clinical, 2016 Background: Advanced brain MR techniques are useful tools for differentiating Progressive Supranuclear Palsy from Parkinson's disease, although time-consuming and unlikely to be used all together in routine clinical work.
Stefano Zanigni +14 more
doaj +1 more source
Clinical Parkinsonism & Related Disorders, 2020 Background and Purpose: The clinical diagnosis of progressive supranuclear palsy can be challenging, as the clinical presentation overlaps with that of Parkinson's disease and multiple system atrophy.
Jessica Cooperrider +2 more
doaj +1 more source
The Egyptian Journal of Internal Medicine, 2016 Patients with Parkinson′s disease are at risk of developing aspiration pneumonia. Pulmonary embolism is a rare but life-threatening complication in such patients, but could the same be true in progressive supranuclear palsy, an atypical form of ...
Robin G Manappallil, Vinod Krishnan
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Progressive supranuclear palsy (PSP) has many clinical features overlapping with other Parkinson syndromes and differentiation on clinical ground is difficult.
Baraka Alphonce +4 more
doaj +1 more source
Environmental Risk Factors for Progressive Supranuclear Palsy [PDF]
Journal of Movement Disorders, 2021 Typically, progressive supranuclear palsy (PSP) is clinically characterized by slow vertical saccades or supranuclear gaze palsy, levodopa-resistant parkinsonism with predominant axial symptoms, and cognitive executive impairment.
Hee Kyung Park +2 more
doaj +1 more source
Procerus sign: Mechanism, clinical usefulness, and controversies
Annals of Indian Academy of Neurology, 2018 This sign is observed in atypical parkinsonism mainly in Progressive Supranuclear Palsy. The exact mechanism of this sign is not clear but the contraction of the Corrugator Supercilii muscle is the most important factor for the generation of vertical ...
Shakya Bhattacharjee
doaj +1 more source